Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·114 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Not detected.
Recent guests
Recent episodes
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
Jun 5, 2026
21m 28s
How Advanced Drug Delivery Could Improve Existing Cancer Treatments [Video Edition]
Jun 5, 2026
21m 28s
BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)
Jun 2, 2026
17m 20s
BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) [Video Edition]
Jun 2, 2026
17m 20s
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
May 15, 2026
19m 44s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/5/26 | How Advanced Drug Delivery Could Improve Existing Cancer Treatments✨ | advanced drug deliverycancer treatments+4 | — | Sapu003Deciparticle(TM)+5 | — | drug deliverycancer therapy+5 | — | 21m 28s | |
| 6/5/26 | How Advanced Drug Delivery Could Improve Existing Cancer Treatments [Video Edition]✨ | advanced drug deliverycancer treatments+4 | — | Sapu003Deciparticle(TM)+5 | — | oncologydrug delivery+5 | — | 21m 28s | |
| 6/2/26 | BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)✨ | biopharmaceuticalsmultiple sclerosis+3 | Anthony Durkacz | Lucid-MSQuantum BioPharma Ltd.+3 | Austin, Texas | Quantum BioPharmaAnthony Durkacz+4 | — | 17m 20s | |
| 6/2/26 | BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) [Video Edition]✨ | biopharmaceuticalsmultiple sclerosis+3 | Anthony Durkacz | Lucid-MSQuantum BioPharma Ltd.+3 | Austin, Texas | Quantum BioPharmamultiple sclerosis+3 | — | 17m 20s | |
| 5/15/26 | CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities✨ | CNS drug deliverybiotech market opportunities+4 | — | Oncotelic Therapeutics Inc.Biogen Inc.+3 | Alzheimer’s disease | CNSdrug delivery+5 | — | 19m 44s | |
| 5/15/26 | CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities [Video Edition]✨ | CNS drug deliverybiotech market opportunities+3 | — | Oncotelic Therapeutics Inc.Biogen Inc.+3 | Alzheimer’s disease | CNSdrug delivery+5 | — | 19m 44s | |
| 5/15/26 | The Next Generation of the GLP-1 Revolution Is Already Underway✨ | GLP-1 receptor agonistsobesity treatment+3 | — | GEP-44SureNano Science Ltd.+5 | global | GLP-1obesity+5 | — | 22m 06s | |
| 5/15/26 | The Next Generation of the GLP-1 Revolution Is Already Underway [Video Edition]✨ | GLP-1 receptor agonistsobesity treatment+3 | — | GEP-44SureNano Science Ltd.+6 | global | GLP-1obesity+3 | — | 22m 06s | |
| 4/24/26 | When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech✨ | biotechnologydrug pipelines+3 | — | Oncotelic Therapeutics Inc.GMP Bio+3 | — | biotechdrug commercialization+3 | — | 18m 32s | |
| 4/24/26 | When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech [Video Edition]✨ | biotechnologydrug pipelines+3 | — | Oncotelic Therapeutics Inc.Sarepta Therapeutics Inc.+2 | — | biotechdrug commercialization+3 | — | 18m 32s |
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.